Sign Out
Advise the patient/parent to talk to the doctor before using Act-HIB: If child has a weakened immune system, or if child is treated with corticosteroids, cytotoxic drugs, radiotherapy of other drugs likely to weaken the immune system. The doctor may wait until the end of the treatment; If child has bleeding disorders such as a decrease in platelets (thrombocytopenia) or clotting disorders, because of the risk of bleeding which may occur during intramuscular administration; If child is allergic (hypersensitive) to latex. The tip caps of the syringes without a needle attached contain a natural latex derivative that could cause allergic reactions; Fainting can occur following, or even before, any needle injection. Also, advise the patient/parent to inform the doctor or nurse if the child has fainted with previous injection.
Act-HIB 10 micrograms/0.5 ml, powder and solvent for solution for injection in pre-filled syringe contains sodium: Act-HIB contains less than 1 mmol (23 mg) of sodium per dose, which means that it is essentially "sodium free".
Driving and using machines: Not applicable.
Use in Children: Not applicable.
